Phase II, unicenter, open, randomized trial to evaluate the response of Th17 and T regulatory lymphocytes to 24 weeks supplementation with cholecalciferol in patients with arterial hypertension, obesity and vitamin D deficiency.
Phase of Trial: Phase II
Latest Information Update: 07 Mar 2018
At a glance
- Drugs Colecalciferol (Primary)
- Indications Vitamin D deficiency
- Focus Pharmacodynamics
- 07 Mar 2018 New trial record